BDI Pharma’s ability to diversify its product portfolio while not sacrificing our service based business model had been an instrumental part of this company’s continued growth.
Columbia, SC (PRWEB) September 13, 2011
BDI Pharma, Inc. (BDI), the nation’s fastest growing national distributor of specialty biotherapeutics, posted the largest monthly Sales Revenues in the company’s 16 year history during the month of August, 2011. Record sales across multiple product lines within BDI’s diverse portfolio, specifically Hemophilia and Oncology, contributed to this significant milestone.
“To achieve this type of success in today’s business climate is a true testament to our team’s vision and tenacity, particularly as changes in Healthcare have presented dynamic challenges to our industry. BDI Pharma’s ability to diversify its product portfolio while not sacrificing our service based business model had been an instrumental part of this company’s continued growth,” said Richard J. Gaton, BDI Pharma co-founder and President during a recent corporate roundtable.
About BDI Pharma, Inc.
Since its founding in 1995, BDI Pharma has defined its customer-centric approach to serving the nation's healthcare community through innovative supply solutions, unparalleled customer service, extensive product knowledge, 24/7 emergency availability and urgent-need delivery. An open-access resource for reference material, educational literature, market data and online ordering, bdipharma.com (ivig.com) has become an industry-renowned point of reference. Proprietary programs created for specialty veterinarians - 4legpharma.com, product consignment - consignadvantage.com, flu pre-booking and general vaccine ordering - securivax.com, and purchasing/reward programs - qoreprogram.com and securigam.com round out a family of solutions tailored to the needs of the healthcare community at large.
BDI Pharma’s portfolio includes branded and generic specialty pharmaceuticals, chemotherapy products, vaccines, albumin, IVIG, coagulation factors, high-titer or “hyper” immune globulins, and other specialty injectables. BDI Pharma is recognized as an “ADR,” or Authorized Distributor of Record, for all of the manufacturers it represents.